Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged Acute Lymphoblastic Leukemia’ [ChIP-seq]
Ontology highlight
ABSTRACT: Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged Acute Lymphoblastic Leukemia’ [ChIP-seq]
PROVIDER: PRJNA962573 | ENA |
REPOSITORIES: ENA
ACCESS DATA